Form 4: Quest Diagnostics SVP Acquires Shares Through Dividend Reinvestment

Patrick Plewman, SVP at Quest Diagnostics, acquired 81 shares of common stock through a dividend reinvestment plan at a price of $164.423 per share.

Summary

• On April 21, 2025, Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, acquired 81 shares of common stock.
• The acquisition was made through a dividend reinvestment plan.
• The price per share was $164.423.
• Following the transaction, Plewman beneficially owns 21,087 shares of Quest Diagnostics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction (dividend reinvestment) by an executive, indicating a continued stake in the company but not necessarily a strong positive or negative signal.

Positives

• The acquisition of shares through a dividend reinvestment plan demonstrates the executive's continued investment in the company.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. Dividend reinvestment plans are a common way for employees and executives to increase their stake in the company.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine acquisition of shares through a dividend reinvestment plan.

Key Dates

Keywords

Quest Diagnostics, DGX, Patrick Plewman, dividend reinvestment plan, Form 4, insider trading, beneficial ownership, SVP, Diagnostic Services